Faralimomab

Modify Date: 2024-09-16 06:57:50

Faralimomab Structure
Faralimomab structure
Common Name Faralimomab
CAS Number 167816-91-3 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Faralimomab


Faralimomab (64G12) is an immunomodulator, and a murine anti-IFNA1 IgG1 mAb[1].

 Names

Name Faralimomab

 Faralimomab Biological Activity

Description Faralimomab (64G12) is an immunomodulator, and a murine anti-IFNA1 IgG1 mAb[1].
Related Catalog
Target

IFNA1[1]

References

[1]. Pelletier J P R, et al. Passive monoclonal and polyclonal antibody therapies[M]//Immunologic Concepts in Transfusion Medicine. Elsevier, 2020: 251-348.

 Chemical & Physical Properties

No Any Chemical & Physical Properties